Results 191 to 200 of about 3,117,564 (363)

A Technical Framework for Predicting Regulatory Deficiencies in Pharmaceutical Chemistry, Manufacturing, and Controls (CMC) Submissions Using Machine Learning. [PDF]

Cureus
Modi P.
europepmc   +1 more source

Design for Additive Manufacturing

, 2019
M. Thompson, G. Moroni, Tom Vaneker, Georges Fadel, R. I. Campbell, Ian Gibson, Alain Bernard, J. Schulz, P. Graf, B. Ahuja, F. Martina   +10 more
semanticscholar   +1 more source

Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells

FEBS Open Bio, EarlyView.
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel, Sam Bennett, Natalie Ehlinger, Nelson Cook, Katelyn Marvin, Caleb L. Lines, Sam Reyes, Brooke Kirby, Shawn M. Ellerbroek   +8 more
wiley   +1 more source

Jeffrey Manufacturing Company Machine Shop

, 1920
Interior view of the new machine shop of the Jeffrey Manufacturing Company, Columbus, Ohio, 1920.
Fred A. Behmer for the Jeffrey Manufacturing Company (Photographer)
core  

The in vivo revolution in CAR-T therapy medicinal products: challenges and regulatory prospects. [PDF]

Signal Transduct Target Ther
Lu J, Cui J, Dong J, Yan L, Wang X, Zhou D, Lu S, Wei W.   +7 more
europepmc   +1 more source

Lean manufacturing: context, practice bundles, and performance

, 2003
Rachna Shah, Peter T. Ward
semanticscholar   +1 more source

Proteasomal degradation of intracellularly expressed Amblyomin‐X limits suicide gene therapy potential in melanoma cells

FEBS Open Bio, EarlyView.
This study explores the feasibility of expressing the antitumoral protein Amblyomin‐X through a suicide gene therapy approach and investigates its intracellular fate after gene delivery. Although the gene is efficiently expressed, melanoma cells rapidly degrade the Amblyomin‐X protein via proteasome activity.
Victor Dal Posolo Cinel, Carlos DeOcesano Pereira, Aline Ramos Maia Lobba, Melissa Regina Fessel, Ana Marisa Chudzinski‐Tavassi   +4 more
wiley   +1 more source

Jeffrey Manufacturing Company Brass Foundry

, 1915
Interior of the Jeffrey Manufacturing Company brass foundry in Columbus, Ohio, 1915. A traveling crane is overhead.
Fred A. Behmer for the Jeffrey Manufacturing Company (Photographer)
core  

Idecabtagene vicleucel manufacturing and clinical value of out-of-specification products in relapsed and refractory MM. [PDF]

Blood Adv
Sidana S, Lin Y, Cowan AJ, Rodríguez-Otero P, Scheid C, Mueller PJ, Broussard C, Krengel P, Li Y, Piault R, Corrao A, Ho C, Patel K.   +12 more
europepmc   +1 more source

MiR‐513a promotes human erythroid differentiation by modulating c‐Jun

FEBS Open Bio, EarlyView.
During early human erythropoiesis, miR‐513a promoted erythroid differentiation in primary human CD34+ hematopoietic stem‐progenitor cells and human TF‐1 erythroleukemic cells by indirectly decreasing c‐Jun and phospho‐c‐Jun expression, which are associated with increased GATA1 expression.
MinJung Kim, Brittany Taylor, Shannon Bolten, Christian L. Eberly, Mahliya Abdurahman, T. Michael Creed, Acong Yang, Taylor L. Hatchet, Tristan Dyson, Shuo Gu, Curt I. Civin, Tami J. Kingsbury   +11 more
wiley   +1 more source